Cathepsin L is required for ecotropic murine leukemia virus infection in NIH3T3 cells

Virology

Volumn 394, Issue 2, 2009, Pages 227-234

  Yoshii, Hiroaki ^a   Kamiyama, Haruka ^a   Minematsu, Kazuo ^a   Goto, Kensuke ^b   Mizota, Tsutomu ^a   Oishi, Kazunori ^a,c   Katunuma, Nobuhiko ^d   Yamamoto, Naoki ^a,e   Kubo, Yoshinao ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Cathepsin B; Cathepsin L; Ecotropic murine leukemia virus

Indexed keywords

CATHEPSIN B; CATHEPSIN L; N (3 PROPYLCARBAMOYLOXIRANE 2 CARBONYL)ISOLEUCYLPROLINE;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ECOTROPIC VIRUS; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TARGET CELL; VIRION; VIRUS ATTACHMENT; VIRUS INFECTION; VIRUS INHIBITION;

ANIMALS; BASE SEQUENCE; CATHEPSIN B; CATHEPSIN L; CELL LINE; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; EPOXY COMPOUNDS; HOST-PATHOGEN INTERACTIONS; HUMANS; LEUKEMIA VIRUS, MURINE; LEUKEMIA, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; NIH 3T3 CELLS; PYRIDINES; RATS; RECEPTORS, VIRUS; RECOMBINANT PROTEINS; RETROVIRIDAE INFECTIONS; RNA, MESSENGER; TUMOR VIRUS INFECTIONS;

MURINE LEUKEMIA VIRUS;

EID: 70449102689     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.08.045     Document Type: Article

References (34)

1. Alain T., Kim T.S., Lun X., Liacini A., Schiff L.A., Senger D.L., and Forsyth P.A. Proteolytic disassembly is a critical determinant for reovirus oncolysis. Mol. Ther. 15 8 (2007) 1512-1521
2. Albritton L.M., Tseng L., Scadden D., and Cunningham J.M. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57 4 (1989) 659-666
3. Chambers A.F., Colella R., Denhardt D.T., and Wilson S.M. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells. Mol. Carcinog. 5 3 (1992) 238-245
4. Chandran K., Sullivan N.J., Felbor U., Whelan S.P., and Cunningham J.M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308 5728 (2005) 1643-1645
5. Conus S., and Simon H.U. Cathepsins: key modulators of cell death and inflammatory responses. Biochem. Pharmacol. 76 11 (2008) 1374-1382
6. Cosset F.L., Takeuchi Y., Battini J.L., Weiss R.A., and Collins M.K. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69 12 (1995) 7430-7436
7. Ebert D.H., Deussing J., Peters C., and Dermody T.S. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J. Biol. Chem. 277 27 (2002) 24609-24617
8. Gogos J.A., Thompson R., Lowry W., Sloane B.F., Weintraub H., and Horwitz M. Gene trapping in differentiating cell lines: regulation of the lysosomal protease cathepsin B in skeletal myoblast growth and fusion. J. Cell Biol. 134 4 (1996) 837-847
9. Guicciardi M.E., Miyoshi H., Bronk S.F., and Gores G.J. Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. Am. J. Pathol. 159 6 (2001) 2045-2054
10. He X.H., Li J.J., Xie Y.H., Tang Y.T., Yao G.F., Qin W.X., Wan D.F., and Gu J.R. Altered gene expression profiles of NIH3T3 cells regulated by human lung cancer associated gene CT120. Cell Res. 14 6 (2004) 487-496
11. Jane D.T., Morvay L.C., Allen F., Sloane B.F., and Dufresne M.J. Selective inhibition of cathepsin B with cell-permeable CA074Me negatively affects L6 rat myoblast differentiation. Biochem. Cell Biol. 80 4 (2002) 457-465
12. Jones J.S., and Risser R. Cell fusion induced by the murine leukemia virus envelope glycoprotein. J. Virol. 67 1 (1993) 67-74
13. Katen L.J., Januszeski M.M., Anderson W.F., Hasenkrug K.J., and Evans L.H. Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway. J. Virol. 75 11 (2001) 5018-5026
14. Katunuma N., Murata E., Kakegawa H., Matsui A., Tsuzuki H., Tsuge H., Turk D., Turk V., Fukushima M., Tada Y., and Asao T. Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo. FEBS Lett. 458 1 (1999) 6-10
15. Kubo Y., and Amanuma H. Mutational analysis of the R peptide cleavage site of Moloney murine leukaemia virus envelope protein. J. Gen. Virol. 84 Pt 8 (2003) 2253-2257
16. Kubo Y., Ishimoto A., and Amanuma H. N-Linked glycosylation is required for XC cell-specific syncytium formation by the R peptide-containing envelope protein of ecotropic murine leukemia viruses. J. Virol. 77 13 (2003) 7510-7516
17. Kubo Y., Ishimoto A., Ono T., Yoshii H., Tominaga C., Mitani C., Amanuma H., and Yamamoto N. Determinant for the inhibition of ecotropic murine leukemia virus infection by N-linked glycosylation of the rat receptor. Virology 330 1 (2004) 82-91
18. Kubo Y., Tominaga C., Yoshii H., Kamiyama H., Mitani C., Amanuma H., and Yamamoto N. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry. Arch. Virol. 152 12 (2007) 2169-2182
19. Kubo Y., Yoshii H., Kamiyama H., Tominaga C., Tanaka Y., Sato H., and Yamamoto N. Ezrin, Radixin, and Moesin (ERM) proteins function as pleiotropic regulators of human immunodeficiency virus type 1 infection. Virology 375 1 (2008) 130-140
20. Kumar P., Nachagari D., Fields C., Franks J., and Albritton L.M. Host cell cathepsins potentiate Moloney murine leukemia virus infection. J. Virol. 81 19 (2007) 10506-10514
21. Lavillette D., Ruggieri A., Russell S.J., and Cosset F.L. Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments. J. Virol. 74 1 (2000) 295-304
22. McClure M.O., Sommerfelt M.A., Marsh M., and Weiss R.A. The pH independence of mammalian retrovirus infection. J. Gen. Virol. 71 Pt 4 (1990) 767-773
23. Montaser M., Lalmanach G., and Mach L. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells. Biol. Chem. 383 7-8 (2002) 1305-1308
24. Pager C.T., and Dutch R.E. Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J. Virol. 79 20 (2005) 12714-12720
25. Pear W.S., Nolan G.P., Scott M.L., and Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad Sci. U.S.A. 90 18 (1993) 8392-8396
26. Qiu Z., Hingley S.T., Simmons G., Yu C., Das Sarma J., Bates P., and Weiss S.R. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J. Virol. 80 12 (2006) 5768-5776
27. Ragheb J.A., and Anderson W.F. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 68 5 (1994) 3220-3231
28. Rein A., Mirro J., Haynes J.G., Ernst S.M., and Nagashima K. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 68 3 (1994) 1773-1781
29. Simmons G., Gosalia D.N., Rennekamp A.J., Reeves J.D., Diamond S.L., and Bates P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad Sci. U.S.A. 102 33 (2005) 11876-11881
30. Soda Y., Shimizu N., Jinno A., Liu H.Y., Kanbe K., Kitamura T., and Hoshino H. Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line. Biochem. Biophys. Res. Commun. 258 2 (1999) 313-321
31. Tsuge H., Nishimura T., Tada Y., Asao T., Turk D., Turk V., and Katunuma N. Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex. Biochem. Biophys. Res. Commun. 266 2 (1999) 411-416
32. Wilson C.A., Marsh J.W., and Eiden M.V. The requirements for viral entry differ from those for virally induced syncytium formation in NIH 3T3/DTras cells exposed to Moloney murine leukemia virus. J. Virol. 66 12 (1992) 7262-7269
33. Wong P.K., Yuen P.H., and Kaufman S.J. Induction of syncytia by Moloney murine leukemia virus in myoblasts defective in differentiation. J. Virol. 21 1 (1977) 319-327
34. Yoshii H., Kamiyama H., Amanuma H., Oishi K., Yamamoto N., and Kubo Y. Mechanisms underlying glycosylation-mediated loss of ecotropic receptor function in murine MDTF cells and implications for receptor evolution. J. Gen. Virol. 89 Pt 1 (2008) 297-305